为您找到"
syre
"相关结果约100,000,000个
Syre, the textile impact company hyperscaling textile-to-textile recycling, today announces a Memorandum of Understanding (MoU) with the province of Binh Dinh, Vietnam. The MoU reflects a partnership with Binh Dinh with the intention of establishing Syre's first Gigascale recycling plant in the province.
Find the latest Spyre Therapeutics, Inc. (SYRE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Syre is a 2017 alternative hip hop album by American rapper Jaden Smith, featuring guest appearances from ASAP Rocky, Raury, and Willow Smith. The album title is a reference to his full name and the main character in a story of coming of age and chasing the sunset.
SYRE | Complete Spyre Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get the latest Spyre Therapeutics Inc (SYRE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
About SYRE. Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the α4β7 integrin being developed for the treatment of IBD (ulcerative ...
Discover real-time Spyre Therapeutics, Inc. Common Stock (SYRE) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
SYRE is a 2017 album by Jaden Smith, featuring songs like "Icon", "Falcon" and "Batman". The album is named after one of his middle names and explores his personal journey and identity.
View Spyre Therapeutics, Inc SYRE investment & stock information. Get the latest Spyre Therapeutics, Inc SYRE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Since then, SYRE stock has decreased by 25.7% and is now trading at $17.29. View the best growth stocks for 2025 here. How were Spyre Therapeutics' earnings last quarter? Spyre Therapeutics, Inc. (NASDAQ:SYRE) posted its quarterly earnings data on Thursday, May, 8th. The company reported ($0.74) earnings per share (EPS) for the quarter, beating ...